Bulletin
Investor Alert

Pacira BioSciences Inc.

NAS: PCRX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202929053/composite

$

60.77

Change

0.00 0.00%

Volume

Volume 43,346

Sep 18, 2020, 4:32 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202929053/composite

Previous close

$ 59.89

$ 60.77

Change

+0.88 +1.47%

Day low

Day high

$59.12

$61.62

Open
Open: 60.91

52 week low

52 week high

$27.46

$64.44

Open

Market cap

$2.60B

Average volume

594,393

P/E ratio

N/A

Rev. per Employee

$651,114

EPS

-0.24

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/pcrx

MarketWatch News on PCRX

  1. Pacira BioSciences started at buy with $60 stock price target at SunTrust RH

    8:33 a.m. Jan. 24, 2020

    - Tomi Kilgore

  2. Sachem Head Capital Says A Split-Up Eagle Will Fly

    9:30 p.m. July 12, 2019

    - Barron's Online

  3. Pacira Pharmaceuticals reiterated as sell at Stifel

    8:36 a.m. March 8, 2019

    - Ciara Linnane

  4. Resolute’s Resolve

    8:00 p.m. Oct. 26, 2018

    - Barron's Online

  5. Pacira Pharmaceuticals started at neutral with $47 stock price target at J.P. Morgan

    9:12 a.m. Dec. 18, 2017

    - Tomi Kilgore

  6. Pacira Pharma names Scott Braunstein COO, Richard Scranton chief scientific officer

    8:39 a.m. Dec. 7, 2017

    - Ciara Linnane

  7. Johnson & Johnson earnings: All eyes on hurricane impact

    5:22 a.m. Oct. 17, 2017

    - Emma Court

  8. Pacira Pharmaceuticals started at perform at Oppenheimer

    9:08 a.m. Sept. 7, 2017

    - Tomi Kilgore

  9. Pacira Pharmaceuticals upgraded to neutral from sell at Janney

    8:22 a.m. Aug. 21, 2017

    - Tonya Garcia

  10. Which Biotech Earnings Will Outperform?

    2:27 p.m. July 18, 2017

    - Barrons Blogs

  11. Pacira Pharmaceuticals started at outperform with $58 stock price target at RBC Capital

    7:15 a.m. April 13, 2017

    - Tomi Kilgore

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/pcrx

Other News on PCRX

  1. Pacira Biosciences (PCRX) Investor Presentation - Slideshow

    1:38 p.m. Sept. 18, 2020

    - Seeking Alpha

  2. Soleno (SLNO) in Focus: Stock Moves 6.3% Higher

    8:35 a.m. Aug. 20, 2020

    - Zacks.com

  3. Avadel (AVDL) Surges: Stock Moves 7.8% Higher

    8:42 a.m. Aug. 18, 2020

    - Zacks.com

  4. Avenue Therapeutics (ATXI) Misses Earnings Estimates in Q2

    10:33 a.m. Aug. 17, 2020

    - Zacks.com

  5. Axsome's (AXSM) Earnings Beat in Q2, Pipeline Progresses

    1:05 p.m. Aug. 11, 2020

    - Zacks.com

  6. 10-Q: PACIRA BIOSCIENCES, INC.

    5:04 p.m. Aug. 6, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  7. IPO Update: PainReform Readies U.S. IPO Plan

    2:25 p.m. Aug. 6, 2020

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/pcrx

Press Releases on PCRX

  1. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.